Results 191 to 200 of about 19,917 (245)

Underprescription of Clozapine: A Narrative Review Regarding ‘Clozaphobia’

Human Psychopharmacology: Clinical and Experimental, Volume 41, Issue 3, May 2026.
ABSTRACT This review aims to examine the appropriateness of the term ‘clozaphobia’ to characterise the obstacles contributing to the underprescription of clozapine (CLZ). English‐language, peer‐reviewed studies addressing clinicians', patients' and/or carers' attitudes toward CLZ were considered eligible for full‐text review.
Rafael Brito Castro, Joaquim J. Ferreira, João Gama‐Marques   +2 more
wiley   +1 more source

Psychotic Risk Associated With Cannabinoid Use: A Case Report of Ekbom-Like Delusional Infestation. [PDF]

Cureus
Pao Trigo M, Cavaco Rogrigues J, Luz B, Sá Couto J, Mota Oliveira M.   +4 more
europepmc   +1 more source

Leukocytosis and tobacco use during pregnancy

International Journal of Gynecology &Obstetrics, Volume 173, Issue 2, Page 989-995, May 2026.
Abstract Objective Factors such as tobacco and other toxic substance use, obesity, associated comorbidity, and intercurrent infections can cause a proinflammatory state and modify analytical parameters. The objective of this study is to identify smoking‐induced leukocytosis in pregnant women across all three trimesters of pregnancy to aid in their ...
Nayara López Carpintero, Carolina Giráldez‐García, Rodrigo Carmona Camacho   +2 more
wiley   +1 more source

Dexamethasone-Induced Avascular Necrosis of the Femoral Head in a Patient With Major Depressive Disorder: A Rare Case Report. [PDF]

Clin Case Rep
Bidaki R, Najafabadi AK, Hasani F.
europepmc   +1 more source

2025 Consensus Clinical Management Guidelines for Niemann‐Pick Disease Type C

Journal of Inherited Metabolic Disease, Volume 49, Issue 3, May 2026.
ABSTRACT In 2018, the International Niemann‐Pick Disease Alliance (INPDA) and the International Niemann‐Pick Disease Registry (INPDR) developed and published comprehensive clinical management guidelines to support inclusive and standardized care pathways in Niemann‐Pick disease type C (NPC)—an ultra‐rare, autosomal recessive, neurovisceral lysosomal ...
Tarekegn Hiwot, Forbes D. Porter, Tatiana Bremova‐Ertl, Uma Ramaswami, Caroline Hastings, Bénédicte Héron, Justin Hopkin, Joella Melville, Hernan Amartino, Mireia del Toro, Federica Deodato, Fatih Ezgü, Paul Gissen, James B. Gibson, Can Ficicioglu, Roberto Giugliani, Orna Staretz‐Chacham, Frances Platt, Nathalie Guffon, Kristina Julich, Nikola Kresojević, Anna Lehman, Yann Nadjar, Susanne A. Schneider, Simon Jones, Eugen Mengel, Michel Tchan, Mark Walterfang, Ozlem Goker‐Alpan, Charlotte Dawson, Sandra Cowie, Toni Mathieson, Elizabeth Berry‐Kravis, Marc C. Patterson   +33 more
wiley   +1 more source

Clinical Outcome Assessments in Parkinson's Disease: A Scoping Review of Current Rating Scales and Future Needs

Movement Disorders Clinical Practice, Volume 13, Issue 5, Page 1124-1146, May 2026.
Abstract Background Clinical outcome assessments (COAs) are essential for evaluating symptom severity, treatment response, and disease progression in Parkinson's disease (PD). As clinical knowledge evolves, it is necessary to revisit the recommendation status on the COAs to ensure their continued relevance and validity. Objectives To provide an updated
Evita Papathoma, Panagiota Tsitsi, Nirosen Vijiaratnam, Camila Aquino, Stephen R. Duma, Norbert Kovacs, Kigocha Lameck Okeng'o, Aparna Wagle Shukla, Roongroj Bhidayasiri, Tiago A. Mestre, Alvaro Sanchez Ferro, Alberto J. Espay, Michelle H.S. Tosin, Matej Skorvanek, Ioanna Markaki   +14 more
wiley   +1 more source

Hashimoto's Encephalopathy-Induced Personality Changes: A Rare Case Report. [PDF]

Indian J Psychol Med
Vijayan S, Selvaraj A, Ramanathan B, Coumaravelou M.   +3 more
europepmc   +1 more source

Carrier screening in the reproductive setting—Are there medical implications for the heterozygote?—A guide for clinicians

Pregnancy, Volume 2, Issue 3, May 2026.
Abstract Carrier screening for genetic conditions performed preconception or during pregnancy allows identification of fetal risk for inherited autosomal recessive and X‐linked conditions. The goal is to identify at‐risk patients/couples and offer them reproductive options such as preimplantation genetic diagnosis, prenatal testing, or targeted newborn
Emily B. Rosenfeld, Nicole Kasatkin, Bi Liu Yu, Milen Velinov, Justin S. Brandt, Elena Ashkinadze   +5 more
wiley   +1 more source